Cargando…

Use of Bone Resorption Inhibitors in Metastatic Castration-Resistant Prostate Cancer—20 Years Later, and the Answer Is Still Yes

Detalles Bibliográficos
Autores principales:	Takvorian, Samuel U., Haas, Naomi B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073645/ https://www.ncbi.nlm.nih.gov/pubmed/34292339 http://dx.doi.org/10.1001/jamanetworkopen.2021.17159

Ejemplares similares

Prostate Cancer: Is There Still a Role for Systematic Biopsies? Yes
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

Is there still a place for vinorelbine in advanced metastatic castration resistant prostate cancer?
por: Roviello, Giandomenico, et al.
Publicado: (2019)

The answer to how is yes: acting on what matters
por: Block, Peter
Publicado: (2003)

Colloids Yes or No? - a “Gretchen Question” Answered
por: Adamik, Katja-Nicole, et al.
Publicado: (2021)

Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem
por: La Vecchia, Maria, et al.
Publicado: (2022)

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
por: El-Amm, Joelle, et al.
Publicado: (2016)

Novel Dormancy Mechanism of Castration Resistance in Bone Metastatic Prostate Cancer Organoids
por: Lee, Sanghee, et al.
Publicado: (2022)

Should we fear the robot revolution? (the correct answer is yes)
por: Berg, Andrew, et al.
Publicado: (2018)

The CDK-activating kinase Cdk7: Taking yes for an answer
por: Schachter, Miriam Merzel, et al.
Publicado: (2013)

Are We Modular Lying Cues Detectors? The Answer Is “Yes, Sometimes”.
por: Arminjon, Mathieu, et al.
Publicado: (2015)

Is Lipoprotein(a) Clinically Actionable with Today’s Evidence? The Answer is Yes
por: Ma, Gary S., et al.
Publicado: (2023)

Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy
por: Francini, Edoardo, et al.
Publicado: (2021)

Bone marrow involvement in patients with metastatic castration sensitive prostate cancer
por: Shahait, Mohammed, et al.
Publicado: (2022)

Sperm washing – yes or no? An open issue still to be debated
por: Fenizia, Claudio, et al.
Publicado: (2020)

Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: Yes
por: da Costa, Walter Henriques, et al.
Publicado: (2016)

Bone resorption predicts for skeletal complications in metastatic bone disease
por: Brown, J E, et al.
Publicado: (2003)

Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms
por: El-Amm, Joelle, et al.
Publicado: (2013)

Predicting bone scan positivity in non-metastatic castration-resistant prostate cancer
por: Moreira, Daniel M., et al.
Publicado: (2015)

Why Great Leaders Don't Take Yes for an Answer: Managing for Conflict and Consensus
por: Roberto, Michael
Publicado: (2013)

It’s Not Just a Yes or No Answer: Expressions of Local Health Department Accreditation
por: Meyerson, Beth E., et al.
Publicado: (2016)

Utilization and Outcomes of Surgical Castration in Comparison to Medical Castration in Metastatic Prostate Cancer
por: Garje, Rohan, et al.
Publicado: (2019)

Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer
por: Armstrong, Andrew J., et al.
Publicado: (2019)

γδ-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancer
por: Frieling, Jeremy S., et al.
Publicado: (2023)

Genes, cells, and biobanks: Yes, there’s still a consent problem
por: Caulfield, Timothy, et al.
Publicado: (2017)

Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
por: Mai, Lixin, et al.
Publicado: (2020)

Covert Intention to Answer “Yes” or “No” Can Be Decoded from Single-Trial Electroencephalograms (EEGs)
por: Choi, Jeong Woo, et al.
Publicado: (2019)

Radium-223 in metastatic castration resistant prostate cancer
por: Vuong, Winston, et al.
Publicado: (2014)

Treatment sequencing in metastatic castrate-resistant prostate cancer
por: Sartor, Oliver, et al.
Publicado: (2014)

Abiraterone in the treatment of metastatic castration-resistant prostate cancer
por: Mostaghel, Elahe A
Publicado: (2014)

Enzalutamide for patients with metastatic castration-resistant prostate cancer
por: Ramadan, Wijdan H, et al.
Publicado: (2015)

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
por: Rodriguez-Vida, Alejo, et al.
Publicado: (2015)

PSMA theragnostics for metastatic castration resistant prostate cancer
por: Song, Hong, et al.
Publicado: (2022)

Bone scan positivity in non-metastatic, castrate-resistant prostate cancer: external validation study
por: Johnston, Ashley W., et al.
Publicado: (2020)

The Influence of Prednisone on the Efficacy of Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer
por: Teply, Benjamin A., et al.
Publicado: (2015)

Surgical Castration in Hormone-Refractory Metastatic Prostate Cancer Patients Can Be an Alternative for Medical Castration
por: Zaitsu, Masayoshi, et al.
Publicado: (2012)

Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells
por: Chatterji, Tanushree, et al.
Publicado: (2015)

PCSD1, a new patient-derived model of bone metastatic prostate cancer, is castrate-resistant in the bone-niche
por: Godebu, Elana, et al.
Publicado: (2014)

Predictors for progression of metastatic prostate cancer to castration-resistant prostate cancer in Indians
por: Sureka, Sanjoy Kumar, et al.
Publicado: (2016)

Impact of Extraskeletal Metastases on Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases
por: Lobo-Martins, Soraia, et al.
Publicado: (2020)

Impact of timing of radium‑223 administration on the survival of patients with bone metastatic castration‑resistant prostate cancer
por: Makita, Kenji, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6spndd1b1l4iv3b3g85m3d1udc